Lasmiditan

Chemical formula: C₁₉H₁₈F₃N₃O₂  Molecular mass: 377.367 g/mol  PubChem compound: 11610526

Therapeutic indications

Lasmiditan is indicated for:

Headache phase of migraine attacks

Population group: only adults (18 years old or older)

Lasmiditan is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Lasmiditan is contraindicated in the following cases:

Lactation

Lactation

Effects on ability to drive and use machines

Effects on ability to drive and use machines

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2024: RAYVOW Film-coated tablet
Structured Product Labeling (SPL/PLR) 2020: REYVOW Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈